<DOC>
	<DOCNO>NCT00483899</DOCNO>
	<brief_summary>This study design look safety aspect effect repeat inhaled dos GW870086X mild asthmatic develop drug use asthma chronic obstructive pulmonary disease ( COPD )</brief_summary>
	<brief_title>Examine Effect Repeat Inhaled Doses GW870086X Lung Function Mild Asthmatic Male Subjects</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : Male subject age 1855 Documented history bronchial asthma diagnose least 6 month ago . Only treat shortacting beta2agonist therapy e.g . Ventolin Documented sensitivity adenosine mono phosphate ( AMP ) screen visit Demonstrate repeatable reproducable response inhale AMP runin visit Exclusion criterion : Any significant illness disease History life threaten asthma History respiratory tract infection Subjects take medication asthma , condition , compatible study . Smoker Subjects oversensitive corticosteroid History drug alcohol abuse Donated blood within last 3 month Been involve another clinical trial last 3 month Subjects work night shift Subjects undergoing desensitisation therapy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>GW870086X Asthma Crossover repeat dose inhale</keyword>
</DOC>